BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9798601)

  • 1. Immunology. Sinking surveillance's flagship.
    Klein G; Klein E
    Nature; 1998 Oct; 395(6701):441, 443-4. PubMed ID: 9774094
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.
    Ferrand V; Li C; Romeo G; Yin L
    J Med Virol; 2003 May; 70(1):131-6. PubMed ID: 12629654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why commonplace encounters turn to fatal attraction.
    Sadelain M; Kieff E
    Nat Genet; 1998 Oct; 20(2):103-4. PubMed ID: 9771693
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene mutation responsible for fatal EBV complication discovered.
    McCarthy M
    Lancet; 1998 Oct; 352(9134):1125. PubMed ID: 9798601
    [No Abstract]   [Full Text] [Related]  

  • 5. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
    Gaspar HB; Sharifi R; Gilmour KC; Thrasher AJ
    Br J Haematol; 2002 Dec; 119(3):585-95. PubMed ID: 12437631
    [No Abstract]   [Full Text] [Related]  

  • 7. X-linked lymphoproliferative syndrome.
    Nelson DL; Terhorst C
    Clin Exp Immunol; 2000 Dec; 122(3):291-5. PubMed ID: 11122230
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 9. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.